Concentra®, the nation’s leader in occupational medicine, today announced the opening of a new medical center in Waukegan, ...

JPMorgan analyst Lisa Gill raised the firm’s price target on Concentra (CON) to $30 from $29 and keeps an Overweight rating on the shares.

ADDISON, Texas, March 10, 2025--(BUSINESS WIRE)--Concentra ®, the nation’s leader in occupational medicine, today announced ...

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...

Concentra acquired five clinics in Miami-Dade County. The clinics specialize in work injury care and drug testing. OM ...

Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...

Oppenheimer Asset Management Inc. cut its holdings in Concentra Group Holdings Parent, Inc. (NYSE:CON – Free Report) by 33.0% ...

Wells Fargo lowered the firm’s price target on Concentra (CON) to $25 from $27 and keeps an Overweight rating on the shares. The firm is also ...

Concentra®, the nation’s leader in occupational medicine, today announced the acquisition of the assets of Physicians Health Center (PHC) and OM Management (OMM). “This acquisition will make ...

We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at ...

Concentra Group (CON) has been beaten down lately with too much selling pressure. While the stock has lost 8.5% over the past four weeks, there is light at the end of the tunnel as it is now in ...